Kevin F. McLaughlin, SVP, CFO and Treasurer at ACCELERON PHARMA INC (XLRN), sold 85,056 shares at $130.14 ($11.1M) on 2020-12-14, disclosed to the SEC on 2020-12-15.
Open-market sale of $11.1M XLRN by SVP, CFO and Treasurer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $130.14 | 42,528 | $5.5M | 50.0% |
| 2 | $130.14 | 42,528 | $5.5M | 50.0% |
| Total | $130.14 avg | 85,056 | $11.1M | 100% |
| Filing → |
| VCEL | SELL | 2026-02-13 | $243K | — | Filing → |
| IVVD | BUY | 2025-11-20 | $125K | — | Filing → |
| VCEL | SELL | 2025-11-12 | $270K | — | Filing → |